Univest
Univest
  • Markets
  • Aarti Drugs Analyst Review 2027: Record Quarter, Profit Up 83% and a P/E Half the Industry’s

    • November 17, 2026
    • Posted by: Chaitanya Auti
    • Category: Market
    No Comments
    Aarti Drugs Analyst Review 2027: Record Quarter, Profit Up 83% and a P/E Half the Industry's

    Aarti Drugs posted its highest-ever quarterly revenue, EBITDA and profit in Q2 FY27, with profit up 83% on better API pricing. It still trades at about 20 times earnings. We cover the business, margins, volume gap and 2027 triggers.

    read more
  • Aakash Exploration Services Analyst Review 2027: Sales Up 9% but a Q2 Loss. Can This ₹8 Oilfield Stock Recover?

    • November 17, 2026
    • Posted by: Chaitanya Auti
    • Category: Market
    No Comments
    Aakash Exploration Services Analyst Review 2027: Sales Up 9% but a Q2 Loss. Can This ₹8 Oilfield Stock Recover?

    Aakash Exploration Services grew Q2 FY27 sales 9% but slipped to a small loss, and the stock sits near its 52-week low at about ₹8. With no brokerage coverage, we explain the oilfield services model, margins, debt and what 2027 depends on.

    read more
  • AAA Technologies Analyst Review 2027: New Owners, a ₹101 Open Offer and a Stock Now Below It

    • November 17, 2026
    • Posted by: Ankit Jaiswal
    • Category: Market
    No Comments
    AAA Technologies Analyst Review 2027: New Owners, a ₹101 Open Offer and a Stock Now Below It

    AAA Technologies changed hands in 2026 after a ₹101 open offer, yet the stock now trades below that price. FY26 profit fell 41% and auditors qualified the accounts. We look at the cyber audit business, the new owners and 2027 triggers.

    read more
  • A2Z Infra Engineering Analyst Review 2027: Revenue Down 31%, Stock Near Its Low and an Auditor Warning

    • November 17, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    A2Z Infra Engineering Analyst Review 2027: Revenue Down 31%, Stock Near Its Low and an Auditor Warning

    A2Z Infra Engineering’s Q2 FY27 income fell 31% and it slipped back to a small loss, while auditors have questioned its ability to continue as a going concern. We set out the business, the debt settlements and the risks for 2027.

    read more
  • 63 moons technologies Analyst Review 2027: Cyber Arm Lifts Guidance to ₹600 Crore, But the Group Still Loses Money

    • November 17, 2026
    • Posted by: Ankit Jaiswal
    • Category: Market
    No Comments
    63 moons technologies Analyst Review 2027: Cyber Arm Lifts Guidance to ₹600 Crore, But the Group Still Loses Money

    63 moons technologies nearly doubled from its low as cybersecurity arm 63SATS raised FY27 billing guidance to ₹600 crore. Revenue tripled in Q2 FY27, yet the group still lost ₹40 crore. Here is what the numbers say for 2027.

    read more
  • 5Paisa Capital Analyst Review 2027: Revenue Up 12%, Profit Down 26% and an MTF Book Growing 32%

    • November 17, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    5Paisa Capital Analyst Review 2027: Revenue Up 12%, Profit Down 26% and an MTF Book Growing 32%

    5Paisa Capital grew Q2 FY27 revenue 12% and its margin trading book 32%, but profit fell 26% as costs rose. With no verified brokerage targets, we look at the discount broking model, the shift to allied income, valuation and 2027 triggers.

    read more
  • 3P Land Holdings Analyst Review 2027: A Stock at 0.4 Times Book Value. Why Does the Discount Persist?

    • November 17, 2026
    • Posted by: Ankit Jaiswal
    • Category: Market
    No Comments
    3P Land Holdings Analyst Review 2027: A Stock at 0.4 Times Book Value. Why Does the Discount Persist?

    3P Land Holdings trades at about 40% of its book value with no debt and five years of rising profit. With no brokerage coverage, we explain how the holding company earns, why the discount exists and what could change it in 2027.

    read more
  • 3i Infotech Analyst Review 2027: Institutions Cut Their Stake From 14% to 5%. What the Q2 FY27 Numbers Show

    • November 17, 2026
    • Posted by: Ankit Jaiswal
    • Category: Market
    No Comments
    3i Infotech Analyst Review 2027: Institutions Cut Their Stake From 14% to 5%. What the Q2 FY27 Numbers Show

    Domestic institutions cut their 3i Infotech stake from 14.26% to 5.30% in one quarter, while Q2 FY27 profit fell 63% year on year. We look at the turnaround since the FY24 loss, the ₹64 crore rights issue and what 2027 needs to show.

    read more
  • 21st Century Management Services Analyst Review 2027: Two Profitable Quarters After Three Losses. Is the Turn Real?

    • November 17, 2026
    • Posted by: Ankit Jaiswal
    • Category: Market
    No Comments
    21st Century Management Services Analyst Review 2027: Two Profitable Quarters After Three Losses. Is the Turn Real?

    21st Century Management Services swung to profit in the June and September 2026 quarters after three straight losses. With no brokerage coverage, we look at how its income works, its book value, the risks and what 2027 depends on.

    read more
  • 20 Microns Analyst Review 2027: A P/E Under 10, a ₹100 Crore Capex Plan and Margins Under Pressure

    • November 17, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    20 Microns Analyst Review 2027: A P/E Under 10, a ₹100 Crore Capex Plan and Margins Under Pressure

    20 Microns trades under 10 times earnings with five straight years of profit growth, but Q2 FY27 profit fell 21% on energy and freight costs. With no verified brokerage targets, we build the 2027 view from reported numbers.

    read more
  • 1
  • 2
  • 3
  • 4